Literature DB >> 22586313

A new BATTLE in the evolving war on cancer.

Lecia V Sequist1, Alona Muzikansky, Jeffrey A Engelman.   

Abstract

The Biomarker-integrated Approaches of Targeted Therapy for Lung Cancer Elimination (BATTLE) trial couples real-time molecular interrogation of cancer specimens with an adaptive Bayesian clinical trial design.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22586313     DOI： 10.1158/2159-8274.CD-11-0044

Source DB:  PubMed          Journal:  Cancer Discov        ISSN： 2159-8274            Impact factor:   39.397


  3 in total

1.  Adaptive Clinical Trials: Overview of Early-Phase Designs and Challenges.

Authors:  Olga Marchenko; Valerii Fedorov; J Jack Lee; Christy Nolan; José Pinheiro
Journal:  Ther Innov Regul Sci       Date:  2013-11-26       Impact factor: 1.778

Review 2.  Critical appraisal of ramucirumab (IMC-1121B) for cancer treatment: from benchside to clinical use.

Authors:  Giuseppe Aprile; Marta Bonotto; Elena Ongaro; Carmelo Pozzo; Francesco Giuliani
Journal:  Drugs       Date:  2013-12       Impact factor: 9.546

3.  Identification of direct target engagement biomarkers for kinase-targeted therapeutics.

Authors:  Cloud P Paweletz; Jannik N Andersen; Roy Pollock; Kumiko Nagashima; Mansuo L Hayashi; Shangshuan U Yu; Hongbo Guo; Ekaterina V Bobkova; Zangwei Xu; Alan Northrup; Peter Blume-Jensen; Ronald C Hendrickson; An Chi
Journal:  PLoS One       Date:  2011-10-24       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.